# Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)

> **NCT06004388** · PHASE3 · COMPLETED · sponsor: **Click Therapeutics, Inc.** · enrollment: 110 (actual)

## Conditions studied

- Migraine
- Episodic Migraine
- Headache
- Headache, Migraine

## Interventions

- **DEVICE:** Click Digital Therapeutic

## Key facts

- **NCT ID:** NCT06004388
- **Lead sponsor:** Click Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-21
- **Primary completion:** 2024-05-21
- **Final completion:** 2024-06-05
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06004388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06004388, "Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT06004388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*